COVID 19 Vaccine – WHO Action and Inaction

April 3, 2022

COVID 19 Vaccine 

WHO Action and Inaction

Padmini Arhant

The latest action by the Geneva based World Health Organization (WHO) against Indian manufactured COVAX – the corona virus vaccine by India’s Bharat Biotech suspending exports of Indian vaccine abroad citing inadequate compliance on good manufacturing practice in facility may be one aspect of WHO  guidelines and criteria. 

“Good manufacturing practices are the practices required in order to conform to the guidelines recommended by agencies that control the authorization and licensing of the manufacture and sale of food and beverages, cosmetics, pharmaceutical products, dietary supplements and medical devices.”

However, WHO as the international body maintaining similar policy for all across geographic locations beginning with inspection of Wuhan lab, Hubei Province, China conducting life endangering biohazard research could have averted catastrophic global pandemic.

WHO and other international committee monitoring and inspection of the Wuhan bio lab and others elsewhere are imperative for science and mankind which evidently was not done at least prior to the onset of the deadly pathogen. 

WHO discretionary exercise with Wuhan Virology Institute, China could have saved the world and humanity at large from monumental tragedy and health disaster. 

In the same context, United States and western partners funded biochemical labs in non-western parts of the world such as Ukraine, China and other regions allowing independent open investigation to rule out bio endangerment to mankind is an urgent requirement. The world deserve to be free from any and all kinds of life consuming experiments and endeavors in the aftermath of the COVID 19 unleashed pandemic. 

As for WHO, the international health organization implementing the same gold standard on good manufacturing practice for manufacturers and suppliers in Europe and the United States where serious ethical and scientific protocol negligence have occurred with no immediate response or action from the domestic or international regulatory body would clarify WHO autonomy and uniformity. 

The case in point is the European (Germany) big Pharma Pfizer’s mRNA vaccine clinical trial outsourced to Ventavia Research Group in 2021.

The revelation on Ventavia Research Group as Pfizer’s outsourced research company verifiably engaged in crucial data integrity issues besides ignoring scientific protocol and good practice in the critical Pfizer’s mRNA vaccine clinical trial beckon authorities interest and necessary intervention to protect lives now and in the future. 

Despite alarming details from the whistle blower as former employee of Ventavia Research Group followed up British Medical Journal and New England Journal of Medicine articles in this regard,

The vaccine availability for children in specified age group, pregnant women, booster shot etc. proceeded  without the matter resolved by WHO, United States FDA, CDC and other agencies responsible for public health and safety. 

There was another incident with Johnson & Johnson’s  corona virus vaccine notably with sub-contracted production line in Baltimore, Maryland, United States in March 2021. 

Courtesy: The New York Times.March 31, 2021. 

Factory Mix-Up Ruins Up to 15 Million Vaccine Doses From Johnson & Johnson

“Workers at a plant in Baltimore manufacturing two coronavirus vaccines accidentally conflated the ingredients several weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay authorization of the plant’s production lines.”

In light of these flagrant violations in different settings, WHO role as an international regulatory authority applying the rule on fair and equal compliance in the pharmaceutical industry starting with medical research facilities as well as manufacturing and production centers worldwide without exception would be a refreshing change in the otherwise selective interference.

The international and domestic regulations on pharma products and services especially their outsourced agents and sub-contractors handling production units of vaccine and other pharmaceutical products subject to stringent conformity leaving no room for lapses with uninformed inspections would provide element of trust among disillusioned public and concerned whistle blowers risking their career and life in health care industry. 

Any update on preventive measures and action taken on 2021 Pfizer vaccine clinical data breach brought to relevant authorities notice such as FDA in the United States, Pfizer and Ventavia Research Group actually involved in the matter would address legitimate grievances expressed by whistle blowers and health professionals not barring general public expectation on transparency and accountability. 

Padmini Arhant 

Author & Presenter

Pfizer Documents 



Got something to say?

You must be logged in to post a comment.